Sign in
4

Changes in Ownership

Acurx Pharmaceuticals, Inc. Filed Acc 0001104659-24-072808

Options or other derivatives

  • Director acquired 12,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Donohue James J. Director 2024-06-17 Grant or award · Stock Option +12,000 12,000 D
Loading xslF345X05/tm2417510-2_4seq1.xml…